Lexicon Pharmaceuticals vs. Pfizer: Which Pharma Stocks Are a Better Buy in 2026?
Investors decide between Lexicon pharmaceuticals (NASDAQ:LXRX) and Pfizer (NYSE: PFE) They face a choice between an emerging, high-growth biotech player and an established global pharmaceutical titan with massive scale. These two companies operate at opposite ends of the size spectrum: one focuses on specialized precision medicine while the other manages a broad portfolio of vaccines…